Thank you, Mr. Paul-Hus.
In fact, the supplementary estimates (B) 2020-21, which you have in hand, include two items pertaining to vaccines and spending on drugs. On the one hand, there is an amount of $3.8 billion, which is a non-budgetary appropriation. It is therefore an amount already approved by Parliament. There is also a $5.4-billion amount which requires approval by the House of Commons and the Senate, which is also for spending on the development and supply of vaccines and drugs.
As you can see, these are substantial amounts. They align very well with this remarkably ambitious program—